Recurrent Primary Peritoneal Cancer
Also known as: Recurrent Primary Peritoneal Cavity Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11793 | Niraparib | A poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy. |
| DB12332 | Rucaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat recurrent ovarian and prostate cancers in previously treated adults. |